Curatis Holding AG (XSWX:CURN) Deferred Tax: CHF-0.16 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:CURN Curatis Holding AG XSWX:CURN
30 GF Score
Price CHF19.00
! 4 Warning Signs
View Full Analysis

What is Curatis Holding AG Deferred Tax?

Curatis Holding AG XSWX:CURN -2.31% 30 Deferred Tax is CHF-0.16 Mil as of Dec. 2025. GuruFocus rates XSWX:CURN with a GF Score™ of 30/100. The stock has 4 warning signs investors should review.

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Curatis Holding AG's change in deferred tax for the six months ended in Dec. 2025 was CHF0.01 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Dec. 2025 was CHF-0.16 Mil.

Curatis Holding AG Deferred Tax Related Terms

Curatis Holding AG Deferred Tax Historical Data

* Premium members only.

The historical data trend for Curatis Holding AG's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curatis Holding AG Deferred Tax Chart

Curatis Holding AG Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Deferred Tax
0.00 0.00 0.00 -0.29 -0.13

Curatis Holding AG Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.07 -0.22 -0.14 0.01
XSWX:CURN
30GF Score
Curatis Holding AG XSWX:CURN
Deferred Tax is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Curatis Holding AG Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF-0.16 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Deferred Tax →
What does a Deferred Tax of CHF-0.16 Mil mean?
Curatis Holding AG (XSWX:CURN) has a Deferred Tax of CHF-0.16 Mil as of Dec. 2025. Change in Defered Tax is amount of deferred tax assets or liabilities due to temporary differences in financial and tax accounting. View historical data for Curatis Holding AG.
Is Curatis Holding AG's Deferred Tax too high?
Curatis Holding AG's current Deferred Tax is CHF-0.16 Mil. Overall, Curatis Holding AG has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Curatis Holding AG's Deferred Tax compare to ZTS and UTHR?
Curatis Holding AG's Deferred Tax of CHF-0.16 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Deferred Tax for a Drug Manufacturers company?
A good Deferred Tax depends on the Drug Manufacturers industry context. However, Deferred Tax should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Deferred Tax mean?
A high Deferred Tax can signal that a stock is expensive relative to its fundamentals. Change in Defered Tax is amount of deferred tax assets or liabilities due to temporary differences in financial and tax accounting. View historical data for Curatis Holding AG. Curatis Holding AG's current Deferred Tax is CHF-0.16 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curatis Holding AG stock overvalued right now?
Curatis Holding AG (XSWX:CURN) has a current Deferred Tax of CHF-0.16 Mil. The current Deferred Tax is CHF-0.16 Mil. Curatis Holding AG's overall GF Score™ is 30/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Deferred Tax calculated?
Deferred Tax is calculated from a company's financial statements. For Curatis Holding AG (XSWX:CURN), the current Deferred Tax is CHF-0.16 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Curatis Holding AG Business Description

Other Exchanges CURNz:UK0QNS:UK26U:Germany
Address Weierweg 7, Liestal, CHE, CH-4410
Curatis Holding AG is a specialty pharmaceutical Company with two-pillar. On one hand, the Company trades and distributes specialty medicines in the rare disease and specialty medicines space i.e. acquires, licenses, distributes and promotes pharmaceutical products for the treatment and/or prevention of rare and specialty diseases in Switzerland. On the other hand, it is a drug development Company with a pipeline of product candidates, also predominantly in the orphan drug space.
30GF Score

Get the complete analysis for XSWX:CURN

Deferred Tax is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF19.00
Price